Study of Alteplase for Respiratory Failure in SARS-CoV-2 COVID-19Christopher D. Barrett, Michael B. Yaffe, D. Scott McCaul et al.|CHEST Journal|2021Cited by 53
Adaptive Support Ventilation and Lung-Protective Ventilation in ARDSElias N Baedorf Kassis, Daniel Talmor, Andres Brenes Bastos et al.|Respiratory Care|2022Cited by 17
Health Expectations and Quality of Life After Acute Respiratory FailureAlison E. Turnbull, Julia Crane, Emma M. Lee et al.|CHEST Journal|2023Cited by 12
MUlticenter STudy of tissue plasminogen activator (alteplase) use in COVID‐19 severe respiratory failure (MUST COVID): A retrospective cohort studyChristopher D. Barrett, Michael B. Yaffe, Hunter B. Moore et al.|Research and Practice in Thrombosis and Haemostasis|2022Cited by 9
Hierarchy of Preferred Patient Outcomes Among Survivors of Acute Respiratory FailureSomnath Bose, Samuel M. Brown, Lena Novack et al.|Respiratory Care|2025Cited by 1